RBC Capital analyst Alistair Campbell lowered the firm’s price target on Pharming Group to EUR 1.75 from EUR 2.10 and keeps an Outperform rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
